Brief: Bellicum Reports Q4 Revenue Of $5.1 Mln
12/03/2020 21:43
March 12 (Reuters) - Bellicum Pharmaceuticals Inc BLCM.O :
* BELLICUM REPORTS FOURTH QUARTER AND FULL YEAR 2019
FINANCIAL
RESULTS AND PROVIDES OPERATIONAL UPDATE
* BELLICUM PHARMACEUTICALS INC - QTRLY REVENUE $5.1 MILLION
VERSUS
$312,000
* BELLICUM PHARMACEUTICALS INC - QTRLY LOSS PER SHARE $5.82
* BELLICUM PHARMACEUTICALS INC - MANAGEMENT EXPECTS CASH
UTILIZATION OF $55 TO $65 MILLION IN 2020
Source text for Eikon: ID:nGNX24L5Dj
Further company coverage: BLCM.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview